Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain LGND message board posts where the ticker symbol LGND has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

Related news from
Thu, 28 Mar 2024
15:30:42 +0000
Ligand (LGND) Down 15.5% Since Last Earnings Report: Can It Rebound?
Ligand (LGND) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tue, 26 Mar 2024
22:15:18 +0000
Ligand Pharmaceuticals (LGND) Falls More Steeply Than Broader Market: What Investors Need to Know
In the most recent trading session, Ligand Pharmaceuticals (LGND) closed at $68.64, indicating a -0.88% shift from the previous trading day.
Thu, 21 Mar 2024
13:00:11 +0000
Here is What to Know Beyond Why Ligand Pharmaceuticals Incorporated (LGND) is a Trending Stock
Zacks.com users have recently been watching Ligand (LGND) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Wed, 20 Mar 2024
22:00:19 +0000
Ligand Pharmaceuticals (LGND) Exceeds Market Returns: Some Facts to Consider
In the most recent trading session, Ligand Pharmaceuticals (LGND) closed at $73.11, indicating a +1.25% shift from the previous trading day.
Tue, 19 Mar 2024
13:30:09 +0000
Ligand (LGND) Is Considered a Good Investment by Brokers: Is That True?
According to the average brokerage recommendation (ABR), one should invest in Ligand (LGND). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Thu, 14 Mar 2024
22:00:19 +0000
Ligand Pharmaceuticals (LGND) Declines More Than Market: Some Information for Investors
Ligand Pharmaceuticals (LGND) reachead $71.93 at the closing of the latest trading day, reflecting a -1.14% change compared to its last close.
Fri, 08 Mar 2024
23:00:12 +0000
Ligand Pharmaceuticals (LGND) Gains As Market Dips: What You Should Know
In the latest trading session, Ligand Pharmaceuticals (LGND) closed at $73.77, marking a +1.79% move from the previous day.
Thu, 07 Mar 2024
14:00:10 +0000
Is Trending Stock Ligand Pharmaceuticals Incorporated (LGND) a Buy Now?
Ligand (LGND) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Tue, 05 Mar 2024
21:01:00 +0000
Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference
SAN DIEGO, March 05, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference in Miami on Thursday, March 14, 2024, at 10:45 a.m. Eastern Time.
Mon, 04 Mar 2024
13:00:00 +0000
Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, March 04, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that effective March 1, 2024, Ligand’s Human Capital Management and Compensation Committee approved the grant of a non-qualified stock option award to purchase 15,100 shares of its common stock to one non-executive employee. The grant date for the options was March 1, 2024.
Thu, 29 Feb 2024
14:30:10 +0000
Wall Street Analysts See Ligand (LGND) as a Buy: Should You Invest?
According to the average brokerage recommendation (ABR), one should invest in Ligand (LGND). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Wed, 28 Feb 2024
14:38:29 +0000
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2023 Earnings Call Transcript
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2023 Earnings Call Transcript February 27, 2024 Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.03, expectations were $0.58. LGND isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Korenberg – COO: Operator: Ladies and gentlemen, […]
Wed, 28 Feb 2024
12:34:00 +0000
Ligand (LGND) Q4 Earnings Surpass Estimates, Stock Surges
Ligand Pharmaceuticals (LGND) reports encouraging fourth-quarter results as earnings and sales beat estimates. Management reiterates the 2024 financial outlook.
Wed, 28 Feb 2024
10:59:00 +0000
Ligand Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
Ligand Pharmaceuticals ( NASDAQ:LGND ) Full Year 2023 Results Key Financial Results Revenue: US$131.3m (down 33% from...
Wed, 28 Feb 2024
03:15:09 +0000
Q4 2023 Ligand Pharmaceuticals Inc Earnings Call
Q4 2023 Ligand Pharmaceuticals Inc Earnings Call
Tue, 27 Feb 2024
12:52:10 +0000
Ligand Pharmaceuticals Inc (LGND) Reports Solid Earnings Amidst Operational Transformation
Q4 and Full Year 2023 Financials Show Growth and Strategic Refocus
Tue, 27 Feb 2024
12:00:00 +0000
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
SAN DIEGO, February 27, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three and twelve months ended December 31, 2023, and provided an operating forecast and business updates. Ligand management will host a conference call and webcast today beginning at 8:30 a.m. Eastern time to discuss this announcement and answer questions.
Thu, 22 Feb 2024
21:01:00 +0000
Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®
SAN DIEGO, February 22, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Eisai Co., Ltd. obtained marketing authorization approval in January 2024 from the Japanese Ministry of Health, Labour and Welfare for the injection formulation of its in-house discovered antiepileptic drug (AED) Fycompa® (perampanel) in Japan as an alternative therapy when oral administration is temporarily not possible. Fycompa is formulated with Captisol®, a Ligand technology.
Tue, 20 Feb 2024
23:00:17 +0000
Why Ligand Pharmaceuticals (LGND) Dipped More Than Broader Market Today
Ligand Pharmaceuticals (LGND) reachead $72.37 at the closing of the latest trading day, reflecting a -1.75% change compared to its last close.
Fri, 16 Feb 2024
13:00:00 +0000
Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires
SAN DIEGO, February 16, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced it has appointed Richard Baxter to the role of Senior Vice President of Investment Operations, and Karen Reeves, M.D., to Senior Vice President of Clinical Strategy and Investments. Both executives will report to CEO Todd Davis.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "VF is a great group of value seeking investors, who are most generous in sharing their research, news, business expertise, and investment experience. It is an invaluable resource, and brings many 'lessons learned' to the group." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2024, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards